[1]
2025. GLP-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THERAPEUTIC POTENTIAL AND CLINICAL CHALLENGES. International Journal of Innovative Technologies in Social Science. 1, 3(47) (Jul. 2025). DOI:https://doi.org/10.31435/ijitss.3(47).2025.3493.